Back

Cellid announces capital increase as South Korean biotech stocks surge

Verifying
  • Cellid announced a capital increase involving Huniverse Global.
  • South Korean pharmaceutical and biotech stocks rose sharply across the board.
  • Control-stake transactions emerged in rapid succession across the industry.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.